Details of the Drug

General Information of Drug (ID: DMYFAQV)

• Drug Name: N-(pyridin-4-ylmethyl) estradiol-16-carboxamide
• Synonyms: SCHEMBL12379498

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 406.5
  Logarithm of the Partition Coefficient (xlogp); 3.9
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C25H30N2O3
  IUPAC Name: (13S,17S)-3,17-dihydroxy-13-methyl-N-(pyridin-4-ylmethyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16-carboxamide
  Canonical SMILES: C[C@]12CCC3C(C1CC([C@@H]2O)C(=O)NCC4=CC=NC=C4)CCC5=C3C=CC(=C5)O
  InChI: InChI=1S/C25H30N2O3/c1-25-9-6-19-18-5-3-17(28)12-16(18)2-4-20(19)22(25)13-21(23(25)29)24(30)27-14-15-7-10-26-11-8-15/h3,5,7-8,10-12,19-23,28-29H,2,4,6,9,13-14H2,1H3,(H,27,30)/t19?,20?,21?,22?,23-,25-/m0/s1
  InChIKey: PHCMYYPTUPNLMJ-GYDLEPMTSA-N
• Cross-matching ID:
  PubChem CID: 44407377
  TTD ID: D02DYZ

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1)	TTIWB6L	DHB1_HUMAN	Inhibitor	[1]

References

• [1] Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45.